Unknown

Dataset Information

0

Formulary Drug Review: Edaravone.

ABSTRACT: Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

SUBMITTER: Ali ZK 

PROVIDER: S-EPMC5735759 | biostudies-other | 2017 Dec

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Formulary Drug Review: Edaravone.

Ali Zaynah K ZK   Baker Danial E DE  

Hospital pharmacy 20171009 11

Each month, subscribers to <i>The Formulary Monograph Service</i> receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscri  ...[more]

Similar Datasets

Transcriptomics U373MG edaravone and carnosic acid
2019-04-30 | GSE129001 | GEO
Genomics Review of Peradon
| PRJEB33961 | ENA
Unknown Efficacy and safety of edaravone for acute intracerebral haemorrhage: protocol for a systematic review and meta-analysis.
| S-EPMC7440699 | biostudies-literature
Unknown A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?
| S-EPMC2891515 | biostudies-other
Unknown Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits.
| S-EPMC4413288 | biostudies-literature
Unknown Formulary Drug Review: Naldemedine.
| S-EPMC5735716 | biostudies-other
Unknown Formulary Drug Review: Ocrelizumab.
| S-EPMC5735732 | biostudies-other
Unknown Stereotactic Administration of Edaravone Ameliorates Collagenase-Induced Intracerebral Hemorrhage in Rat.
| S-EPMC5095785 | biostudies-literature
Unknown Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease.
| S-EPMC3108992 | biostudies-literature
Unknown Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19.
| S-EPMC7841496 | biostudies-literature